These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7667199)

  • 1. Pharmacokinetic analysis and antiepileptic activity of N-valproyl derivatives of GABA and glycine.
    Hadad S; Bialer M
    Pharm Res; 1995 Jun; 12(6):905-10. PubMed ID: 7667199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic analysis of (E)-2-ene valproyl derivatives of glycine and valproyl derivatives of nipecotic acid.
    Bialer M; Kadry B; Abdul-Hai A; Haj-Yehia A; Sterling J; Herzig Y; Shirvan M
    Biopharm Drug Dispos; 1996 Oct; 17(7):565-75. PubMed ID: 8894115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetic and pharmacodynamic analysis of phthaloyl glycine derivatives with potential antiepileptic activity.
    abu Salach O; Hadad S; Haj-Yehia A; Sussan S; Bialer M
    Pharm Res; 1994 Oct; 11(10):1429-34. PubMed ID: 7855047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic analysis and antiepileptic activity of two new isomers of N-valproyl glycinamide.
    Hadad S; Bialer M
    Biopharm Drug Dispos; 1997 Oct; 18(7):557-66. PubMed ID: 9330777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic considerations in the design of better and safer new antiepileptic drugs.
    Bialer M
    J Control Release; 1999 Nov; 62(1-2):187-92. PubMed ID: 10518650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and antiepileptic activity of valproyl hydroxamic acid derivatives.
    Levi M; Yagen B; Bialer M
    Pharm Res; 1997 Feb; 14(2):213-7. PubMed ID: 9090712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The disposition of valproyl glycinamide and valproyl glycine in rats.
    Blotnik S; Bergman F; Bialer M
    Pharm Res; 1997 Jul; 14(7):873-8. PubMed ID: 9244143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic analysis and anticonvulsant activity of glycine and glycinamide derivatives.
    Sussan S; Dagan A; Bialer M
    Epilepsy Res; 1999 Jan; 33(1):11-21. PubMed ID: 10022362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-pharmacokinetic-pharmacodynamic relationships of N-alkyl derivatives of the new antiepileptic drug valproyl glycinamide.
    Spiegelstein O; Yagen B; Bialer M
    Epilepsia; 1999 May; 40(5):545-52. PubMed ID: 10386522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic analysis and antiepileptic activity of tetra-methylcyclopropane analogues of valpromide.
    Bialer M; Hadad S; Kadry B; Abdul-Hai A; Haj-Yehia A; Sterling J; Herzig Y; Yagen B
    Pharm Res; 1996 Feb; 13(2):284-9. PubMed ID: 8932450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structural requirements for the design of antiepileptic-glycine derivatives.
    Sussan S; Dagan A; Blotnik S; Bialer M
    Epilepsy Res; 1999 Apr; 34(2-3):207-20. PubMed ID: 10210036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet?
    Isoherranen N; Yagen B; Bialer M
    Curr Opin Neurol; 2003 Apr; 16(2):203-11. PubMed ID: 12644750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of GABA analogues on various components of maximum electroshock-induced seizures in mice.
    Habibuddin M; Bhowmick S; Pal M; Pal SP
    Indian J Exp Biol; 1994 Mar; 32(3):218-20. PubMed ID: 8070845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-valproyl-L-phenylalanine as new potential antiepileptic drug: synthesis, characterization and in vitro studies on stability, toxicity and anticonvulsant efficacy.
    De Caro V; Scaturro AL; Sutera FM; Avellone G; Schiera G; Ferrantelli E; Carafa M; Rizzo V; Carletti F; Sardo P; Giannola LI
    Med Chem; 2014; 11(1):30-40. PubMed ID: 24813685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic analysis and anticonvulsant activity of two polyesteric prodrugs of valproic acid.
    Hadad S; Vree TB; van der Kleijn E; Bialer M
    Biopharm Drug Dispos; 1993 Jan; 14(1):51-9. PubMed ID: 8427944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic and pharmacokinetic analysis of CNS-active constitutional isomers of valnoctamide and sec-butylpropylacetamide--Amide derivatives of valproic acid.
    Mawasi H; Shekh-Ahmad T; Finnell RH; Wlodarczyk BJ; Bialer M
    Epilepsy Behav; 2015 May; 46():72-8. PubMed ID: 25863940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure activity relationship of human microsomal epoxide hydrolase inhibition by amide and acid analogues of valproic acid.
    Spiegelstein O; Kroetz DL; Levy RH; Yagen B; Hurst SI; Levi M; Haj-Yehia A; Bialer M
    Pharm Res; 2000 Feb; 17(2):216-21. PubMed ID: 10751038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and anticonvulsant activity of three monoesteric prodrugs of valproic acid.
    Badir K; Haj-Yehia A; Vree TB; van der Kleijn E; Bialer M
    Pharm Res; 1991 Jun; 8(6):750-3. PubMed ID: 2062805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gas chromatographic determination of novel valproyl taurinamide derivatives in mouse and dog plasma.
    Isoherranen N; Yagen B; Spiegelstein O; Steinman A; Finnell RH; Bialer M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 May; 788(1):125-36. PubMed ID: 12668078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of GABA-valproic acid derivatives and evaluation of their anticonvulsant and antioxidant activity.
    Rekatas GV; Tani E; Demopoulos VJ; Kourounakis PN
    Arch Pharm (Weinheim); 1996; 329(8-9):393-8. PubMed ID: 8915099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.